Please note: The Research + Innovation office will be closed for the holidays from noon on December 24 through January 2nd, inclusive. 鉂勶笍 Veuillez noter que le bureau de la Recherche et de l'Innovation sera ferm茅 pour les vacances du 24聽d茅cembre 脿 midi jusqu鈥檃u 2聽janvier inclus.
Under the leadership of the Vice-President, Dominique B茅rub茅, Research and Innovation (R+I) promotes and advances research across 不良研究所, through service to the research community.
不良研究所
Research and Innovation (R+I) is responsible for the promotion and advancement of research across 不良研究所 and serves the research community in a variety of ways. Specifically, R+I directs the University鈥檚 overall institutional research mandate, manages the support services framework for research initiatives, and oversees outreach to key international institutions.
Throughout the R+I portfolio, particular emphasis is placed on the cultivation, development, and support of interdisciplinary research initiatives and innovation.
Leadership Team
Learn about R+I's leadership team.
R+I Portfolio
Learn about R+I's portfolio.
Learn More
Learn more about 不良研究所 R+I's research performance, major projects, reports, and policies.
Initiatives & Entities
Learn about 不良研究所's various Research Units and Core Facilities.
Strategic Research Plan
Learn more about R+I's focus on research and innovation through our strategic research plan (SRP).
Research Advisory Council
The Research Advisory Council (RAC) is the primary forum for exchange, discussion, and updates on University-wide research related dossiers between the Office of 不良研究所 Research and Innovation, the hospital Research Institutes, and the Faculties.
DNA to RNA (D2R) Initiative
An inclusive聽Canadian approach to genomic-based RNA therapeutics, seeking funding through the Canada First Research Excellence Fund (CFREF) program.